Hubei Hendi Pharmaceutical

Hubei Hendi Pharmaceutical is a China-based commercial pharmaceutical manufacturer focused on chemical active pharmaceutical ingredients, intermediates, and finished dosage products, with additional CDMO services. The company has built its business around non-steroidal anti-inflammatory APIs such as ibuprofen, dexibuprofen, and ibuprofen arginine, while also supplying cardiovascular, anti-tumor, and anticholinergic APIs. It markets or develops formulations including ibuprofen products, torasemide tablets and injections, febuxostat tablets, and other small-molecule generics derived from its API base. Hendi operates manufacturing in Jingmen, Hubei, and R&D/commercial functions in Wuhan, and has emphasized an integrated "API + formulations" strategy. The company is publicly listed in Shenzhen and appears to be one of the larger Chinese ibuprofen API producers with export activity and regulated-market manufacturing capabilities.